it is also not a gift I would wish for anyone else to receive.
it is also not a gift I would wish for anyone else to receive.
New York, N.Y. – December 17, 2019 – TrialJectory, an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials and remove barriers to advanced treatment options, announced today that the Company has closed a $2.7 million seed financing round, led by Contour Venture Partners. Proceeds from the financing will expedite the growth of TrialJectory’s platform, which includes adding more clinical trials for different cancer types and expanding the Company’s outreach across the medical, pharmaceutical and patient communities. To date, TrialJectory has matched thousands of patients for clinical trial enrollment and continues to add new studies to the platform each week.
“As cancer is the second leading cause of death for Americans – with thousands of new cases diagnosed each year – having access to advanced treatment options is a necessity, not a privilege, as new trials provide better outcomes to patients,” said Tzvia Bader, TrialJectory CEO and co-founder. “What’s more, one of the top obstacles that oncologists face today is the lack of clinical trial access for patients, which is due to the availability of more treatment options overall. Additionally, it is a very complex process to match the right patient with the right treatment, especially with the rise of personalized medicine.”
“Not only is TrialJectory’s platform expanding access to new treatments for patients, but it’s also revolutionizing the trial recruitment process as a whole by reducing operational costs and enabling new drugs to hit the market sooner,” added Bader. “The bottom line is that patients have the right to take action and find the best treatment for them. Leveraging AI is the key to making this happen and, ultimately, to saving lives.”
TrialJectory currently supports trials for breast cancer, colon cancer, bladder cancer, melanoma and myelodysplastic syndromes (MDS; often called preleukemia). The engine works through mimicking the mind of an oncologist, reading all unstructured treatment descriptions and extracting the data that’s relevant to the patient. TrialJectory clusters, classifies and standardizes this information, creating a unique database that highlights patient attributes attractive to clinical trials. Patients are then matched to clinical trials through self-reported, dynamic questionnaire answers and can filter the trials and share the information with their oncologists to move forward in the process if appropriate.
“TrialJectory’s work – driven by a highly experienced management team, comprised of both oncology and technology experts – is disrupting and reshaping how we think about traditional cancer care today,” concluded Bob Greene, lead investor. “Even more important, it is empowering patients to take back control of their treatment, and we look forward to watching TrialJectory’s platform continue to grow quickly. We believe that the Company has the potential to become a go-to resource for the global medical community to help doctors provide personalized, matched treatment options to patients in need everywhere.”
Clinical trials are designed to find new or better ways to treat, prevent or screen for a medical condition. These trials involve human participants to evaluate the safety and effectiveness of new approaches/ treatments for diseases, including cancer.
In clinical trials, patients receive specific interventions according to a research plan, such as new drugs or devices, procedures, and even changes to patients’ behavior (diet). Researchers are always exploring different combinations of therapies, whether it be introducing a new drug or using a standard (approved) treatment in a new way to find the best and most effective approach to treating patients.
There are many different reasons why people decide to participate in clinical trials. In the past, it was mainly due to standard treatments not being as effective as they should be, or the side effects were too severe. But today, due to the innovations in research and the effectiveness of new drugs with fewer side effects the National Comprehensive Cancer Network (NCCN) has updated their guidelines, where clinical trials are recommended as the best management for cancer patients.
Participating in clinical trials can present both benefits and risks, and it is important to stay informed, and to speak with your loved ones and doctors to decide if a clinical trial is right for you.
In order to be able to join a clinical trial, a patient must meet a list of requirements (trial eligibility criteria), which include, among others:
Eligibility criteria for trials are used to help identify patients with a specific disease profile that is intended for the investigated treatment in the trial. This is used by researchers to ensure patients do not have any outstanding conditions that may impact the trial results.
Finding clinical trials can be a long process, where less than 5% of cancer patients are enrolled in trials. This could be due to the lack of suitable patient-friendly tools that help identify trials that match current medical conditions.
We collect your disease profile and match it to trial eligibility criteria. We do the hard work for you, as we know how difficult it is to browse through those complicated medical terms and find the right match for you.
First, we provide you with a list of trials that are right for you. The next step is for you to review and share these options (if you would like) with your doctors. From there, you decide which one you would like to apply to. We will then connect you to a trial site and help facilitate all communications in order to ensure you get access to the best treatment.
I want to enroll in a trial, what do I do?
You have come to the right place, we are here to help. Our job is to make the process of finding a clinical trial simple, as we search clinical trials for you and match them with your individual disease profile. If you would like to get started, click here. Once you have been matched, we will help you apply to the trial, and get started.
Who can I contact?
If you need assistance in learning more about the clinical trial process or have any questions, please contact our clinical team. You can click the Need Help button on the bottom right corner on our website or send us an email. We are here for you.